Ocuphire Pharma
product candidate profile for multiple retinal indications | Ocuphire Pharma
Company
Deck Type
Deck date
October 2022
Slide
50 of 53
Similar slides by Ocuphire Pharma
See diffirences between slides (animation)
Investor Day
January 2022
product candidate profile for multiple retinal indications | Ocuphire Pharma
Related slides by other companies
Oculis
Investor Conference
June 2023
development status | Oculis
Samsara
Investor Presentation
June 2022
product adoption driving multiple growth vectors | Samsara
Oculis
Investor Presentation
April 2024
development status | Oculis
Aeglea BioTherapeutics
Investor Presentation
September 2023
a conservative spy product profile was tested against and morphic as agent | Aeglea BioTherapeutics
Other recent decks by Ocuphire Pharma
See all presentations (10 decks)
Investor Presentation
November 2023
Investor Presentation
August 2023
Investor Presentation
May 2023
Results
January 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights